Postmenopausal Hormone Replacement Therapy, Coronary Heart Disease and Plasma Lipoproteins
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (2) , 25-34
- https://doi.org/10.2165/00003495-199400472-00006
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Estrogen Replacement and Heart DiseaseClinical Obstetrics and Gynecology, 1992
- The menopause and hormone replacement therapyPostgraduate Medical Journal, 1992
- Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal womenThe American Journal of Cardiology, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Risk factors and noncontraceptive estrogen use in women with and without coronary diseaseAmerican Heart Journal, 1989
- Postmenopausal use of estrogen and occlusion of coronary arteriesAmerican Heart Journal, 1988
- Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50New England Journal of Medicine, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984